Major AstraZeneca Investor Urges $118B Pfizer Merger Talks
British fund manager Schroders PLC, a substantial minority shareholder in AstraZeneca PLC, on Tuesday urged the company to reconsider a sweetened £69.4 billion ($118 billion) takeover bid from Pfizer Inc. that...To view the full article, register now.
Already a subscriber? Click here to view full article